Safety, Considerations, and Recommendations GHK-Cu injection is generally regarded as safe when used properly, but several important considerations apply: Regulatory Status: GHK-Cu is not FDA-approved for any medical use
In vitro experiments demonstrated that Akt inhibition markedly upregulated the expression of FTL, FTH, TFR1, and Poly (rC)-binding protein 1 (PCBP1), downregulated FPN1 expression, increased APP expression, enhanced iron storage and uptake, and decreased iron efflux, thereby aggravating neurological injury in SH-SY5Y and C2C12 cells (Halon-Golabek et al., 2024)
However, in a much larger randomized controlled trial of simvastatin and an antioxidant combination of 600 mg of all - rac --tocopherol (297 mg of RRR --tocopherol), 250 mg of vitamin C, and 20 mg of -carotene daily) in more than 20,000 men and women with CHD or diabetes mellitus, the antioxidant combination did not adversely affect the cardioprotective effects of simvastatin therapy over a five-year period (131)
(And while you're at it, you might as well check in with your doctor to talk about which supplements, and in which dosages, you should be taking.)
Given the heterogeneity of genetic mutations (which can take place in different positions along the DNA, thus in different genes) and the resulting increasing number of genetic mouse models that have been generated, different animal models reproduce various aspects of ASD symptomatology, with the best animal model keeping together all three types of validity criteria
GHK-Cu's copper coordination complex can undergo structural rearrangement during freezing as ice crystal formation concentrates solutes and shifts local pH, potentially causing copper dissociation from the peptide and subsequent loss of biological activity upon thawing